NYSE:ABBV looking like a nice potential short coming soon if we reject the top of this wedge. Possible rejection down to the previous resistance turned support flip. Next level of course is the bottom of the wedge.
Order BUY ABBV NYSE Stop 145.78 LMT 145.78 will be automatically canceled at 20230401 01:00:00 EST
ABBV daily bullish hammer beginning of wave 3 wave 5 uptrend that was ABC correction.
Hello dear Traders,
Here is my idea for #ABBV
Price closed above yellow line
Target marked in the chart
Invalidation level marked with red line
IV30 % Rank: 2% Subdued
Good luck!
❤️Please feel free to ask any question in comments. I will try to answer all! Thank you.
Please, support my work with like, thank you!❤️
The PEAD projected a bullish outlook for $ABBV after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 63.64%.
AbbVie Inc. (ABBV) opened today much higher than the 1D MA200 (orange trend-line), which is a strong enough buy signal on its own. Coupled however with the fact that the rebound was achieved on the Higher Lows trend-line that started way back on the COVID (March 23 2020) market bottom, it makes it an even stronger one. In fact on a 2-3 month basis, this is the...
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in...
Hey traders,
My weekly trade idea.
The daily price is forming a textbook Cup&Handle formation. After the consolidation in the handle phase, the price is ready to go higher. The momentum will push the price and in my opinion, it is headed to test the all-time high in the 180$ area.
The Relative Strength Index broke above its trend line and is moving upward to...
A textbook example of cup&handle pattern forming on ABBV, I think its interesting to dig deeper into the company, as its a defensive stock for just the conditions at the current moment.
What Happens when Bearish Harmonic Crabs and Cyphers Meet ??
Of all the major 11 S&P sub-sectors, the Health care (XLV) seems the most technically vunerable. (see insert)
Herein we have a well formed Gartley pattern waiting to roll over.
Drilling down to the major holdings of this index, AbbVie Inc. (ABBV) also looks the most vulnerable and ready to roll...
AbbVie - 30d expiry - We look to Sell a break of 132.58 (stop at 137.03)
133 continues to hold back the bears.
132.75 has been pivotal.
Posted a Double Bottom formation.
A break of the recent low at 132.74 should result in a further move lower.
Our profit targets will be 121.01 and 117.01
Resistance: 154 / 157 / 160
Support: 147 / 142 / 137
Disclaimer –...
NYSE:ABBV
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid...
